Search Within

Victoria M Richon

Formats
  1. Journal Article (49)
  2. Meeting Abstract (37)
  3. Book Section (4)
  4. Conference Paper (1)
Groups
  1. Surgery (11)
  2. Center for Hematologic Malignancies (10)
  3. Department of Medicine (10)
  4. Solid Tumor Oncology Division (8)
  5. Genitourinary Oncology Service (6)
  6. Pediatric Leukemia (6)

More Groups

People
  1. Paul Marks (77)
  2. Richard Rifkind (76)
  3. Xianbo Zhou (11)
  4. Carlos Cordon-Cardo (10)
  5. Hiroaki Kiyokawa (9)
  6. Gisela Venta-Perez (8)

More People

Years
  1. 2004 (2)
  2. 2003 (3)
  3. 2002 (6)
  4. 2001 (11)
  5. 2000 (11)
  6. 1999 (11)

More Years

Publications
  1. Proceedings of the American Association for Cancer Research Annual Meeting (20)
  2. Proceedings of the National Academy of Sciences of the United States of America (11)
  3. Blood (8)
  4. Cancer Research (7)
  5. Clinical Cancer Research (6)
  6. Anticancer Research (5)

More Publications

Publishers
  1. American Association for Cancer Research (35)
  2. National Academy of Sciences (11)
  3. American Society of Hematology (8)
  4. International Institute of Anticancer Research (5)
  5. Nature Publishing Group (4)
  6. Elsevier Science, Inc. (3)

More Publishers

Results (91)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoic acid
    Journal Article

    Coffey, D. C.; Kutko, M. C.; Glick, R. D.; Butler, L. M.; Heller, G.; Rifkind, R. A.; Marks, P. A.; Richon, V. M.; La Quaglia, M. P.
    Cancer Research (2001)

    Fulltext@MSK | Save
  • Histone deacetylase inhibitors: Development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers
    Journal Article

    Richon, V. M.; Zhou, X.; Rifkind, R. A.; Marks, P. A.
    Blood Cells, Molecules, and Diseases (2001)

    Fulltext@MSK | Save
  • SAHA induced histone hyperacetylation of the p21(WAF1) gene precedes transcription
    Meeting Abstract

    Richon, Victoria M.; Sandhoff, T. W.; Rifkind, R. A.; Marks, P. A.
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save
  • Hybrid polar inhibitors of histone deacetylase suppress the growth of the CWR22 human prostate cancer xenograft
    Meeting Abstract

    Butler, L. M.; Higgins, B.; Fox, W. D.; Agus, D. B.; Cordon-Cardo, C.; Scher, H. I.; Richon, V. M.; Rifkind, R. A.; Marks, P. A.
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save
  • Ribosomal protein S3 as a target for differentiation-inducing hybrid polar compounds
    Meeting Abstract

    Zhou, X.; Richon, V. M.; Ngo, L.; Rifkind, R. A.; Marks, P. A.
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save
  • Histone deacetylase inhibitors
    Meeting Abstract

    Richon, V. M.; Breslow, R.; Rifkind, R. A.; Marks, P. A.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • Histone deacetylase inhibitors induce remission in a transgenic model of therapy resistant acute promyelocytic leukemia
    Meeting Abstract

    He, L. Z.; Tolentino, T.; Grayson, P.; Zhong, S.; Warrel, R. P. Jr; Rifkind, R. A.; Marks, P. A.; Richon, V. M.; Pandolfi, P. P.
    Blood (2000)

    Fulltext@MSK | Save
  • Histone deacetylase inhibitors and retinoic acids inhibit growth of human neuroblastoma in vitro
    Journal Article

    Coffey, D. C.; Kutko, M. C.; Glick, R. D.; Swendeman, S. L.; Butler, L.; Rifkind, R.; Marks, P. A.; Richon, V. M.; LaQuaglia, M. P.
    Medical and Pediatric Oncology (2000)

    Fulltext@MSK | Save
  • Histone deacetylase inhibitors: Inducers of differentiation or apoptosis of transformed cells
    Journal Article

    Marks, P. A.; Richon, V. M.; Rifkind, R. A.
    JNCI: Journal of the National Cancer Institute (2000)

    Fulltext@MSK | Save
  • Histone deacetylase 4 associates with extracellular signal-regulated kinases 1 and 2, and its cellular localization is regulated by oncogenic Ras
    Journal Article

    Zhou, X.; Richon, V. M.; Wang, A. H.; Yang, X. J.; Rifkind, R. A.; Marks, P. A.
    Proceedings of the National Academy of Sciences of the United States of America (2000)

    Fulltext@MSK | Save